American Health Packaging has recalled approximately 290 cartons of Sirolimus (1 mg) tablets because the product failed to meet quality standards for impurities and degradation during testing. Sirolimus is a prescription medication used to prevent organ rejection in patients who have received kidney transplants. Consumers should not stop taking their medication without first consulting a healthcare professional, as doing so could pose serious health risks.
The failure to meet impurity and degradation specifications means the medication may contain chemical byproducts or lose its potency over time. This could potentially reduce the effectiveness of the drug in preventing organ rejection or cause unexpected side effects.
Refund and guidance from healthcare professionals
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.